Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2331524rdf:typepubmed:Citationlld:pubmed
pubmed-article:2331524lifeskim:mentionsumls-concept:C0024299lld:lifeskim
pubmed-article:2331524lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2331524lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:2331524lifeskim:mentionsumls-concept:C0019638lld:lifeskim
pubmed-article:2331524lifeskim:mentionsumls-concept:C0024305lld:lifeskim
pubmed-article:2331524lifeskim:mentionsumls-concept:C0008625lld:lifeskim
pubmed-article:2331524lifeskim:mentionsumls-concept:C0085415lld:lifeskim
pubmed-article:2331524lifeskim:mentionsumls-concept:C0683325lld:lifeskim
pubmed-article:2331524lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:2331524lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:2331524lifeskim:mentionsumls-concept:C0027523lld:lifeskim
pubmed-article:2331524pubmed:issue9lld:pubmed
pubmed-article:2331524pubmed:dateCreated1990-6-6lld:pubmed
pubmed-article:2331524pubmed:abstractTextWe describe the chromosomal abnormalities found in 104 previously untreated patients with non-Hodgkin's lymphoma (NHL) and the correlations of these abnormalities with disease characteristics. The cytogenetic method used was a 24- to 48-hour culture, followed by G-banding. Several significant associations were discovered. A trisomy 3 was correlated with high-grade NHL. In the patients with an immunoblastic NHL, an abnormal chromosome no. 3 or 6 was found significantly more frequently. As previously described, a t(14;18) was significantly correlated with a follicular growth pattern. Abnormalities on chromosome no. 17 were correlated with a diffuse histology and a shorter survival. A shorter survival was also correlated with a +5, +6, +18, all abnormalities on chromosome no. 5, or involvement of breakpoint 14q11-12. In a multivariate analysis, these chromosomal abnormalities appeared to be independent prognostic factors and correlated with survival more strongly than any traditional prognostic variable. Patients with a t(11;14)(q13;q32) had an elevated lactate dehydrogenase (LDH). Skin infiltration was correlated with abnormalities on 2p. Abnormalities involving breakpoints 6q11-16 were correlated with B symptoms. Patients with abnormalities involving breakpoints 3q21-25 and 13q21-24 had more frequent bulky disease. The correlations of certain clinical findings with specific chromosomal abnormalities might help unveil the pathogenetic mechanisms of NHL and tailor treatment regimens.lld:pubmed
pubmed-article:2331524pubmed:languageenglld:pubmed
pubmed-article:2331524pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2331524pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2331524pubmed:statusMEDLINElld:pubmed
pubmed-article:2331524pubmed:monthMaylld:pubmed
pubmed-article:2331524pubmed:issn0006-4971lld:pubmed
pubmed-article:2331524pubmed:authorpubmed-author:AndersonJJlld:pubmed
pubmed-article:2331524pubmed:authorpubmed-author:SangerW GWGlld:pubmed
pubmed-article:2331524pubmed:authorpubmed-author:ArmitageJ OJOlld:pubmed
pubmed-article:2331524pubmed:authorpubmed-author:WeisenburgerD...lld:pubmed
pubmed-article:2331524pubmed:authorpubmed-author:SchoutenH CHClld:pubmed
pubmed-article:2331524pubmed:issnTypePrintlld:pubmed
pubmed-article:2331524pubmed:day1lld:pubmed
pubmed-article:2331524pubmed:volume75lld:pubmed
pubmed-article:2331524pubmed:ownerNLMlld:pubmed
pubmed-article:2331524pubmed:authorsCompleteYlld:pubmed
pubmed-article:2331524pubmed:pagination1841-7lld:pubmed
pubmed-article:2331524pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:meshHeadingpubmed-meshheading:2331524-...lld:pubmed
pubmed-article:2331524pubmed:year1990lld:pubmed
pubmed-article:2331524pubmed:articleTitleChromosomal abnormalities in untreated patients with non-Hodgkin's lymphoma: associations with histology, clinical characteristics, and treatment outcome. The Nebraska Lymphoma Study Group.lld:pubmed
pubmed-article:2331524pubmed:affiliationDepartment of Internal Medicine, University of Nebraska Medical Center, Omaha.lld:pubmed
pubmed-article:2331524pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2331524pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2331524lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2331524lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2331524lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2331524lld:pubmed